{"database": "openregs", "table": "documents", "rows": [["FDA-1982-N-0005-0007", "FDA", "FDA-1982-N-0005", "Notice of Final Rule re Lebeling for Oral and Rectal Over-the-Counter Drug Products Containing Aspirin and Nonaspirin Salicylates; Reye's Syndrome Warning", "Notice", "Notice of Final Rule", "2003-04-22T04:00:00Z", 2003, 4, null, null, "2016-10-13T18:03:59Z", null, 0, 0, "090000648050d796"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1982-N-0005-0007"], "units": {}, "query_ms": 0.8287890232168138, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}